Assemblywoman Susan Talamantes Eggman, right, announces the approval of aid-in-dying legislation on Sept. 11. The pharmaceutical company that owns the most commonly used drug has doubled its price.
Assemblywoman Susan Talamantes Eggman, right, announces the approval of aid-in-dying legislation on Sept. 11. The pharmaceutical company that owns the most commonly used drug has doubled its price. Marcus Yam Los Angeles Times
Assemblywoman Susan Talamantes Eggman, right, announces the approval of aid-in-dying legislation on Sept. 11. The pharmaceutical company that owns the most commonly used drug has doubled its price. Marcus Yam Los Angeles Times